Clinical Trials Sponsored by Novus Scientific

Total 1999 results

Boston Scientific Corporation

Completed

ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent (IMPERIAL)

Atherosclerosis of Native Arteries of the Extremities

New Zealand, United States, Belgium, Canada, Japan, Germany, Austria
Boston Scientific Corporation

Completed

Focal Pain Outcomes Using Configurations Applied for Lateral Stimulation (FOCAL)

Chronic Pain

Belgium
Hipra Scientific, S.L.U

Completed

Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain
Boston Scientific Corporation

Completed

Radiopaque Hydrogel Spacer in Patients Undergoing Radiotherapy for Pancreatic Cancer

Pancreatic Cancer

United States
Boston Scientific Corporation

Completed

AXIOS™ for Gallbladder Drainage as an Alternative to Percutaneous Drainage IDE

Cholecystitis, Acute

United States, Belgium
Boston Scientific Corporation

Terminated

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects (REPRISE IV)

Aortic Valve Stenosis

United States, Australia
Boston Scientific Corporation

Completed

A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation

Head Lice | Pediculus Humanus Capitis

United States
Boston Scientific Corporation

Terminated

Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer

Esophageal Cancer | Squamous Cell Carcinoma | Adenocarcinoma of the Esophagus

United States, India, Czechia, Poland
Boston Scientific Corporation

Active, not recruiting

Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong

Non-valvular Atrial Fibrillation

China
Boston Scientific Corporation

Completed

Strategic Management to Optimize Response To Cardiac Resynchronization Therapy (SMART CRT)

Heart Failure

United States, United Kingdom, France, Germany, Netherlands, Spain, Ireland, Canada, Japan, Switzerland, Italy
Boston Scientific Corporation

Completed

Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology (CAP2)

Atrial Fibrillation

United States
Boston Scientific Corporation

Completed

Post-Approval Study of PROMUS Element™ in China (PEChina)

Coronary Artery Disease

China
Boston Scientific Corporation

Completed

Initial Case Series With Exalt Single-Use Duodenoscope

Endoscopic Retrograde Cholangiopancreatography

United States
Boston Scientific Corporation

Terminated

Fast-Acting Subperception Study (FAST) (FAST)

Chronic Pain

United States
Boston Scientific Corporation

Completed

Combining Mechanisms for Better Outcomes (COMBO) (COMBO)

Back Pain | Chronic Pain

United States
Boston Scientific Corporation

Completed

Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU) (VIEW-VLU)

Venous Leg Ulcer

United States, Canada
Boston Scientific Corporation

Completed

RESPOND Post Market Study (RESPOND)

Aortic Valve Stenosis

Spain, Italy, Netherlands, United Kingdom, Germany, Israel, New Zealand, Finland, Sweden, Colombia, Norway, Poland, Switzerland
Boston Scientific Corporation

Completed

To Evaluate the Safety and Efficacy of LithoVue Ureteroscope System in Chinese Patients With Urinary Disease (LithoVue)

Urinary Tract Disease

China
Boston Scientific Corporation

Completed

Observation of ImageReady™ MR Conditional Defibrillation System in China

Arrhythmia

China
Boston Scientific Corporation

Completed

Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED)

Ventricular Fibrillation | Ventricular Tachycardia | Low Cardiac Output

United States, Belgium, Spain, Netherlands, Germany, France, United Kingdom, Canada, Denmark, Italy, Poland, Puerto Rico, Switzerland
Boston Scientific Corporation

Completed

Study of the WallFlex™ Biliary Partially-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction

Biliary Strictures Caused by Malignant Neoplasms

Italy, Belgium, France, Germany, India, Netherlands
Boston Scientific Corporation

Completed

Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation

ACC/AHA/NASPE Class 1, IIa or IIb Indications

Netherlands, Italy, United Kingdom, New Zealand
Boston Scientific Corporation

Completed

A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE48)

Coronary Artery Disease

United States, United Kingdom, New Zealand, Latvia
Boston Scientific Corporation

Completed

COMFORT: A Multicenter, Open-label, Randomized, Crossover Study (COMFORT)

Varicose Veins

United States
Boston Scientific Corporation

Terminated

Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma (IDEB-glioma)

Glioma

France, Germany
Boston Scientific Corporation

Completed

Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence (VANISH-2)

Varicose Veins

United States
Boston Scientific Corporation

Completed

Validity of Electronic Diary for Monitoring Varicose Veins Symptoms

Varicose Veins

United Kingdom
Boston Scientific Corporation

Completed

Electronic Repositioning With Acuity and Easytrak Leads (ERACE)

Heart Failure

Germany
Boston Scientific Corporation

Completed

VIRTUS: An Evaluation of the Vici™ Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction (VIRTUS)

Chronic Venous Disorder | Venous Outflow Obstruction | Symptomatic Venous Outflow Obstruction of Iliofemoral Vein

United States, Ireland, United Kingdom, Netherlands, France, Germany, Spain
Boston Scientific Corporation

Completed

Xenform Postmarket Surveillance Study (Xenform)

Pelvic Organ Prolapse

United States
Boston Scientific Corporation

Completed

Value of Multiple Modalities Using the Spectra WaveWriter Spinal Cord Stimulator System (VERITAS)

Back Pain | Chronic Pain

United States
Boston Scientific Corporation

Completed

INGEVITY™ Observational Trial (GENTLE)

Bradycardia

Spain, Ireland, Portugal, Belgium, Korea, Republic of, Switzerland, France, Austria, Germany, Italy, Norway, Sweden, United Kingdom
Boston Scientific Corporation

Completed

AIR Extension Study - Long-Term Safety of Alair Treated Subjects (AIRx)

Asthma

Canada, Brazil, United Kingdom
Boston Scientific Corporation

Completed

Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx)

Stress Urinary Incontinence

United States, Australia
Boston Scientific Corporation

Completed

VELOCITY: A Study to Characterize Real-World Outcomes of Spinal Cord Stimulation

Chronic Pain

United Kingdom, Germany, Italy, Netherlands
Boston Scientific Corporation

Terminated

Spinal Cord Stimulation (SCS) for Neuropathic Pain of Back or Lower Extremity

Pain | Back Pain | Lower Extremity Pain | Intractable Neuropathic Pain

United States
Boston Scientific Corporation

Terminated

Spinal Cord Stimulation for Chronic and Intractable Back Pain

Back Pain

United States
Boston Scientific Corporation

Terminated

Study of Occipital Nerve Stimulation for Drug Refractory Migraine (PRISM UK)

Migraine

United Kingdom
Boston Scientific Corporation

Completed

Study to Characterize Acute and Chronic Directional Aspects of Deep Brain Stimulation (DIRECT-DBS)

Parkinson Disease

France, Netherlands, Germany
Boston Scientific Corporation

Completed

Vercise Implantable Stimulator for Treating Parkinson's Disease (VANTAGE)

Idiopathic Parkinson's Disease

Spain, United Kingdom, Germany, Austria, Italy, France
Boston Scientific Corporation

Completed

CUSTOM-DBS: Current Steering to Optimize Deep Brain Stimulation (CUSTOM-DBS)

Parkinson's Disease

United Kingdom, Italy, Germany, United States, Austria
Boston Scientific Corporation

Terminated

Spinal Cord Stimulation With Precision® System Versus Reoperation for Failed Back Surgery Syndrome (Evidence)

Pain | Back Pain | Failed Back Surgery Syndrome

United States, United Kingdom, Canada, France
Boston Scientific Corporation

Completed

Bion Occipital Nerve Stimulation (ONS) Compassionate Use Study

Chronic, Medically Refractory Headache

United States
Boston Scientific Corporation

Completed

GreenLight XPS Laser System Retrospective Chart Review

Benign Prostatic Hyperplasia

United States, Canada
Boston Scientific Corporation

Completed

EVOLVE Short DAPT Study

Coronary Artery Disease

United States, Germany, Latvia, Japan, Sweden, Brazil, Switzerland
Boston Scientific Corporation

Completed

SYNERGY China: Assess SYNERGY Stent in China

Cardiovascular Diseases

China
Boston Scientific Corporation

Terminated

Treatment of Resistant Hypertension by Renal Denervation in China (REDUCE-HTN-CN)

Medication-resistant Hypertension

China
Boston Scientific Corporation

Completed

REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System

Transcatheter Aortic Valve Replacement

Spain, United Kingdom, Australia, France, Germany, Italy, Netherlands, Sweden, Switzerland
Boston Scientific Corporation

Completed

Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy

Pancreatic Cancer

United States, Korea, Republic of, Belgium, Italy, Japan, Canada
Boston Scientific Corporation

Completed

Prospective, Multi-Center All-Comer Biliary Canadian WallFlex Registry

Biliary Strictures

Canada

Clinical Trials Sponsored by Novus Scientific

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations